{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T19:39:54Z","timestamp":1726515594192},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2008,10,1]],"date-time":"2008-10-01T00:00:00Z","timestamp":1222819200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Epilepsy & Behavior"],"published-print":{"date-parts":[[2008,10]]},"DOI":"10.1016\/j.yebeh.2008.06.004","type":"journal-article","created":{"date-parts":[[2008,7,15]],"date-time":"2008-07-15T20:49:01Z","timestamp":1216154941000},"page":"564-566","source":"Crossref","is-referenced-by-count":5,"title":["Impending status epilepticus and anxiety in a pregnant woman treated with levetiracetam"],"prefix":"10.1016","volume":"13","author":[{"given":"Jan","family":"Novy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monica","family":"Hubschmid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrik","family":"Michel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea O.","family":"Rossetti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.yebeh.2008.06.004_bib1","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1212\/01.wnl.0000252941.50833.4a","article-title":"For the Levetiracetam Monotherapy Study G. Comparison of levetiracetam and controlled-release carbamazepine in newly diagnosed epilepsy","volume":"68","author":"Brodie","year":"2007","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2008.06.004_bib2","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S1059-1311(02)00273-X","article-title":"Levetiracetam monotherapy for primary generalised epilepsy","volume":"12","author":"Cohen","year":"2003","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2008.06.004_bib3","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1212\/01.wnl.0000297512.18364.40","article-title":"Levetiracetam for the treatment of idiopathic generalized epilepsy with myoclonic seizures","volume":"70","author":"Noachtar","year":"2008","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2008.06.004_bib4","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1016\/j.yebeh.2006.01.006","article-title":"Determinants of success in the use of oral levetiracetam in status epilepticus","volume":"8","author":"Rossetti","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2008.06.004_bib5","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.yebeh.2008.01.004","article-title":"Intravenous levetiracetam: treatment experience with the first 50 critically ill patients","volume":"12","author":"R\u00fcegg","year":"2008","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2008.06.004_bib6","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.pediatrneurol.2006.09.018","article-title":"Levetiracetam monotherapy in children with epilepsy","volume":"36","author":"Khurana","year":"2007","journal-title":"Pediatr Neurol"},{"key":"10.1016\/j.yebeh.2008.06.004_bib7","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1212\/01.WNL.0000078031.32904.0D","article-title":"Psychiatric adverse events during levetiracetam therapy","volume":"61","author":"Mula","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2008.06.004_bib8","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2165\/00003088-200443110-00002","article-title":"Clinical pharmacokinetics of levetiracetam","volume":"43","author":"Patsalos","year":"2004","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.yebeh.2008.06.004_bib9","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0920-1211(02)00250-4","article-title":"Effects of antiepileptic comedication on levetiracetam pharmacokinetics: a pooled analysis of data from randomized adjunctive therapy trials","volume":"53","author":"Perucca","year":"2003","journal-title":"Epilepsy Res l"},{"key":"10.1016\/j.yebeh.2008.06.004_bib10","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1111\/j.1528-1167.2007.01032.x","article-title":"Pharmacokinetics of levetiracetam during pregnancy, delivery, in the neonatal period, and lactation","volume":"48","author":"Tomson","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.06.004_bib11","doi-asserted-by":"crossref","first-page":"209","DOI":"10.2165\/00003088-200746030-00002","article-title":"Pharmacokinetics and therapeutic drug monitoring of newer antiepileptic drugs during pregnancy and the puerperium","volume":"46","author":"Tomson","year":"2007","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/j.yebeh.2008.06.004_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.seizure.2007.11.027","article-title":"Serum concentration\/dose ratio of levetiracetam before, during and after pregnancy","volume":"17","author":"Westin","year":"2008","journal-title":"Seizure"},{"key":"10.1016\/j.yebeh.2008.06.004_bib13","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1038\/ncpneuro0604","article-title":"Changes in plasma levetiracetam concentrations in pregnant women and their breastfed infants","volume":"3","author":"Perucca","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/j.yebeh.2008.06.004_bib14","first-page":"89","article-title":"The impact of pregnancy and childbirth on the elimination of levetiracetam [abstract]","volume":"46","author":"Pennell","year":"2005","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.06.004_bib15","doi-asserted-by":"crossref","first-page":"1351","DOI":"10.1111\/j.1528-1167.2007.01043.x","article-title":"Effect of age and comedication on levetiracetam pharmacokinetics and tolerability","volume":"48","author":"Hirsch","year":"2007","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.06.004_bib16","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1046\/j.1528-1157.2002.57701.x","article-title":"Levetiracetam does not alter the pharmacokinetics of an oral contraceptive in healthy women","volume":"43","author":"Ragueneau-Majlessi","year":"2002","journal-title":"Epilepsia"},{"key":"10.1016\/j.yebeh.2008.06.004_bib17","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1212\/01.WNL.0000091865.46063.67","article-title":"Discontinuation of levetiracetam because of behavioral side effects: a case \u2013 control study","volume":"61","author":"White","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/j.yebeh.2008.06.004_bib18","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.yebeh.2006.01.003","article-title":"The impact of levetiracetam on challenging behavior","volume":"8","author":"Hurtado","year":"2006","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2008.06.004_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.yebeh.2006.08.008","article-title":"Psychiatric and behavioral side effects of the newer antiepileptic drugs in adults with epilepsy","volume":"10","author":"Weintraub","year":"2007","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2008.06.004_bib20","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.yebeh.2003.12.005","article-title":"Levetiracetam in adult patients with and without learning disability: focus on behavioral adverse effects","volume":"5","author":"Brodtkorb","year":"2004","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2008.06.004_bib21","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yebeh.2003.10.005","article-title":"Epilepsy and anxiety","volume":"4","author":"Vazquez","year":"2003","journal-title":"Epilepsy Behav"},{"key":"10.1016\/j.yebeh.2008.06.004_bib22","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/j.0013-9580.2004.452004.x","article-title":"Recognition of the various expressions of anxiety, psychosis, and aggression in epilepsy","volume":"45","author":"Kanner","year":"2004","journal-title":"Epilepsia"}],"container-title":["Epilepsy & Behavior"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505008001650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1525505008001650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,12,27]],"date-time":"2018-12-27T02:26:01Z","timestamp":1545877561000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1525505008001650"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,10]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,10]]}},"alternative-id":["S1525505008001650"],"URL":"https:\/\/doi.org\/10.1016\/j.yebeh.2008.06.004","relation":{},"ISSN":["1525-5050"],"issn-type":[{"type":"print","value":"1525-5050"}],"subject":[],"published":{"date-parts":[[2008,10]]}}}